This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: LB MYGN SP EXPE


L Brands
(LB - Get Report) was downgraded to hold at TheStreet Ratings.

Myriad Genetics
(MYGN - Get Report) was downgraded from market perform to underperform at JMP Securities. Twelve-month price target is $15. BRCA pricing is lower than expected, JMP Securities said.

SP Plus
(SP - Get Report) was upgraded to buy at TheStreet Ratings.

[Read: 4 Stocks Ready for Breakouts]

Stock Comments / EPS Changes

(EXPE) 12-month price target was raised at Cantor Fitzgerald. Shares are now seen reaching $75. Checks point to higher site visitation in recent months, Cantor Fitzgerald said. Buy rating.

[Read: What Supplemental Health Care Has Been Costing Us]

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
LB $88.46 0.00%
MYGN $34.47 0.00%
SP $24.63 0.00%
AAPL $131.39 0.00%
FB $80.48 0.00%


DOW 18,285.74 +0.34 0.00%
S&P 500 2,130.82 +4.97 0.23%
NASDAQ 5,090.7940 +19.0510 0.38%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs